Ani Pharmaceuticals (ANIP) Amortizatization of Intangibles (2023 - 2026)

Ani Pharmaceuticals has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $453000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $453000.0, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 9.66% YoY), and the FY2025 annual result was $1.8 million, up 15.27% from the prior year.
• Amortizatization of Intangibles came in at $453000.0 for Q1 2026 at Ani Pharmaceuticals, down from $555000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.5 million in Q3 2024 to a low of -$1.7 million in Q4 2024.
• The 4-year median for Amortizatization of Intangibles is $387500.0 (2023), against an average of $417250.0.
• Peak annual rise in Amortizatization of Intangibles reached 518.03% in 2024, while the deepest fall reached 545.67% in 2024.
• Ani Pharmaceuticals' Amortizatization of Intangibles stood at $381000.0 in 2023, then slumped by 545.67% to -$1.7 million in 2024, then jumped by 132.69% to $555000.0 in 2025, then declined by 18.38% to $453000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $453000.0 (Q1 2026), $555000.0 (Q4 2025), and $358000.0 (Q3 2025), per Business Quant data.